Friday, April 12, 2024 12:15:39 PM
What does an insolvent from inception company carrying 8 million of debt have to offer an investor to feel secure investing 30 to 50 millions dollars? The only answer I can come up with is the company.
What was the point or purpose or plan in doing this?
What is more valuable to a lender putting up 30 to 50 million dollars of Risk? Obtaining a company with AS of a billion shares and OS with full dilution of 1.5 billion shares or a company with AS of a billion shares and OS with full dilution 375,000 shares.
It will depend of if news happens before dilution and how much dilution does occur if a RM does happen.
If it is was done so a company like FoxEss could take over dilution could be rather small and slow.
They have enough resources where they don't need to sell shares immediately to finance the project. It would be in there best interest to build equity with a small OS and raise large sums of money later when the company (shares have real value.(Higher the share price less shares needed)
If it was done for Campanella to raise funds on his own then it serves no good for the pre-split shareholders.
Based on the Tweets and their timing, before the company was going to own a US manufacturing facility in ELBA AL, an asset which the lender could take over if the company failed down the road.Now based on the site visit photos, contract expiring and that property is now listed up for leasing it appears that property is no longer in play. The company no longer has the ability to put it up for collateral and hence enacted the RS.
This is only my speculation
Recent SNPW News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2024 09:04:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:15:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:30:36 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 10/23/2023 09:15:31 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 10/13/2023 09:00:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:06:10 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM